146 related articles for article (PubMed ID: 25771378)
21. Activation of natural Hf and Ta in relation to the production of 177Lu.
Medvedev DG; Mausner LF; Greene GA; Hanson AL
Appl Radiat Isot; 2008 Oct; 66(10):1300-6. PubMed ID: 18456503
[TBL] [Abstract][Full Text] [Related]
22. An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applications.
Chakravarty R; Das T; Dash A; Venkatesh M
Nucl Med Biol; 2010 Oct; 37(7):811-20. PubMed ID: 20870156
[TBL] [Abstract][Full Text] [Related]
23. Neutronic simulation of medical radioisotope
Swami HL; Saxena A; Vala S; Abhangi M; Kumar R; Kumar R
Appl Radiat Isot; 2023 May; 195():110743. PubMed ID: 36863265
[TBL] [Abstract][Full Text] [Related]
24. Efficient
Flynn RT; Adams QE; Hopfensperger KM; Wu X; Xu W; Kim Y
Med Phys; 2019 Jul; 46(7):2935-2943. PubMed ID: 31054163
[TBL] [Abstract][Full Text] [Related]
25. The feasibility study of
Golabian A; Hosseini MA; Ahmadi M; Soleimani B; Rezvanifard M
Appl Radiat Isot; 2018 Jan; 131():62-66. PubMed ID: 29173809
[TBL] [Abstract][Full Text] [Related]
26. Consequences of meta-stable (177m)Lu admixture in (177)Lu for patient dosimetry.
Konijnenberg MW
Curr Radiopharm; 2015; 8(2):145-9. PubMed ID: 25771362
[TBL] [Abstract][Full Text] [Related]
27. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Radiolabeling Efficacy by Enhancement of the Chemical form of no Carrier Added
Vosoughi S; Salek N; Arani SS; Samani AB; Maragheh MG
Curr Radiopharm; 2022; 15(1):56-62. PubMed ID: 33480353
[TBL] [Abstract][Full Text] [Related]
29. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
30. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
31. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy.
Das T; Chakraborty S; Sarma HD; Banerjee S; Venakatesh M
Nucl Med Biol; 2010 Jul; 37(5):655-63. PubMed ID: 20610170
[TBL] [Abstract][Full Text] [Related]
32. A systematic study on the utility of CHX-A''-DTPA-NCS and NOTA-NCS as bifunctional chelators for
Pandey U; Gamre N; Lohar SP; Dash A
Appl Radiat Isot; 2017 Sep; 127():1-6. PubMed ID: 28478331
[TBL] [Abstract][Full Text] [Related]
33. Production of glass microspheres comprising 90Y and (177)Lu for treating of hepatic tumors with SPECT imaging capabilities.
Poorbaygi H; Reza Aghamiri SM; Sheibani S; Kamali-Asl A; Mohagheghpoor E
Appl Radiat Isot; 2011 Oct; 69(10):1407-14. PubMed ID: 21723135
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic and laser properties of Er(3+):Yb(3+):LuAl(3)(BO(3))(4) crystal at 1.5-1.6 microm.
Chen Y; Lin Y; Huang J; Gong X; Luo Z; Huang Y
Opt Express; 2010 Jun; 18(13):13700-7. PubMed ID: 20588504
[TBL] [Abstract][Full Text] [Related]
35. Chemistry and bifunctional chelating agents for binding (177)Lu.
Parus JL; Pawlak D; Mikolajczak R; Duatti A
Curr Radiopharm; 2015; 8(2):86-94. PubMed ID: 25771379
[TBL] [Abstract][Full Text] [Related]
36. Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography.
Krause W; Schuhmann-Giampieri G; Bauer M; Press WR; Muschick P
Invest Radiol; 1996 Aug; 31(8):502-11. PubMed ID: 8854197
[TBL] [Abstract][Full Text] [Related]
37. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
38. Experimental half-life determination of ¹⁷⁶Lu.
Kossert K; Jörg G; Gostomski CL
Appl Radiat Isot; 2013 Nov; 81():140-5. PubMed ID: 23570954
[TBL] [Abstract][Full Text] [Related]
39. Formulation and characterization of lutetium-177-labeled stannous (tin) colloid for radiosynovectomy.
Arora G; Singh M; Jha P; Tripathy S; Bal C; Mukherjee A; Shamim SA
Nucl Med Commun; 2017 Jul; 38(7):587-592. PubMed ID: 28538080
[TBL] [Abstract][Full Text] [Related]
40. Nonlinear spectroscopic properties of Yb3+-doped sesquioxides Lu2O3 and Sc2O3.
Soulard R; Moncorgé R; Zinoviev A; Petermann K; Antipov O; Brignon A
Opt Express; 2010 May; 18(11):11173-80. PubMed ID: 20588976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
